On Wednesday, shares of Moderna, Inc. MRNA are trending. The Rapid Response Partnership Vehicle awarded the business $176 million to advance the development of influenza vaccines.
What You Should Know:
The business made this grant announcement on Tuesday. It will help create an mRNA-based vaccine against the H5 influenza virus.
Stéphane Bancel
CEO of Moderna stated that “mRNA vaccine technology offers advantages in efficacy, speed of development, and production scalability and reliability in addressing infectious disease outbreaks, as demonstrated during the COVID-19 pandemic.”
Results from the company’s Phase 1/2 trial of potential vaccine candidates against the H5 and H7 influenza viruses are anticipated in 2024. The study was initiated last year.
What Else: On June 28, the Committee for Medicinal Products for Human Use gave Moderna’s RSV vaccine a good assessment. In the EU, this can result in marketing permission.
How to Purchase Contemporary Stock
By now, you probably want to know how to trade Moderna, whether it’s buying shares or trying to take the corporation on in a wager.
The usual method of purchasing shares is via a brokerage account. Here is a list of potential trading platforms. Many let you purchase “fractional shares,” which let you purchase pieces of stock instead of whole shares. For instance, purchasing a single share of certain stocks, such as Berkshire Hathaway or Amazon.com, might cost thousands of dollars. Brokerages, however, will let you invest a smaller portion of it if that’s all you want to do.
There is more work involved if you want to bet against a company. You will want a broker who will let you “go short” on a stock by lending you the shares to sell, or access to an options trading platform. This resource contains information on shorting stocks. If your broker permits you to trade options, you may take advantage of the decrease in share price by purchasing a put option or selling a call option with a strike price higher than the current market value of the shares.
